Testosterone Gel in Preventing Weakness Caused by Steroid Therapy in Men With Glioma
Status:
Terminated
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Testosterone gel may be effective in preventing or lessening muscle weakness
caused by steroid therapy in men receiving glucocorticoids for newly diagnosed high-grade
glioma.
PURPOSE: This randomized clinical trial is studying how well testosterone gel works in
preventing weakness caused by steroid therapy in men receiving glucocorticoids for newly
diagnosed high-grade glioma.
Phase:
N/A
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins